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Background: FK506 (Tacrolimus) is an important immunosuppressant, produced by industrial biosynthetic
processes using various Streptomyces species. Considering the complex structure of FK506, it is reasonable to expect
complex regulatory networks controlling its biosynthesis. Regulatory elements, present in gene clusters can have a
profound influence on the final yield of target product and can play an important role in development of industrial
bioprocesses.
Results: Three putative regulatory elements, namely fkbR, belonging to the LysR-type family, fkbN, a large
ATP-binding regulator of the LuxR family (LAL-type) and allN, a homologue of AsnC family regulatory proteins, were
identified in the FK506 gene cluster from Streptomyces tsukubaensis NRRL 18488, a progenitor of industrial strains
used for production of FK506. Inactivation of fkbN caused a complete disruption of FK506 biosynthesis, while
inactivation of fkbR resulted in about 80% reduction of FK506 yield. No functional role in the regulation of the
FK506 gene cluster has been observed for the allN gene. Using RT-PCR and a reporter system based on a chalcone
synthase rppA, we demonstrated, that in the wild type as well as in fkbN- and fkbR-inactivated strains, fkbR is
transcribed in all stages of cultivation, even before the onset of FK506 production, whereas fkbN expression is
initiated approximately with the initiation of FK506 production. Surprisingly, inactivation of fkbN (or fkbR) does not
abolish the transcription of the genes in the FK506 gene cluster in general, but may reduce expression of some of
the tested biosynthetic genes. Finally, introduction of a second copy of the fkbR or fkbN genes under the control of
the strong ermE* promoter into the wild type strain resulted in 30% and 55% of yield improvement, respectively.
Conclusions: Our results clearly demonstrate the positive regulatory role of fkbR and fkbN genes in FK506
biosynthesis in S. tsukubaensis NRRL 18488. We have shown that regulatory mechanisms can differ substantially
from other, even apparently closely similar FK506-producing strains, reported in literature. Finally, we have
demonstrated the potential of these genetically modified strains of S. tsukubaensis for improving the yield of
fermentative processes for production of FK506.
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FK506 (Tacrolimus) is a widely used immunosuppressant,
produced by industrial fermentation processes using vari-
ous Streptomyces species. Since its first clinical appearance
in 1989 [1] it has been well established in medicine as an
important immunosuppressant drug. The primary clinical
utility of tacrolimus is prevention of graft rejection follo-
wing organ and reconstructive tissue transplants and also
treatment of skin diseases and eczema [2,3]. In recent
clinical studies FK506-derived compounds have also shown
promise for treatment of neurological disorders [4,5].
A common feature of FK506 (Figure 1A), and its bio-
genetically and structurally related complex polyketides
such as FK520 and rapamycin, is the involvement offkbC fkb
PfkbG













Figure 1 (A) Structures of FK506 and FK520. (B) Schematic representati
right side from the FK506 core PKS region are presented in more detail. Pu
by white arrows. Promoters used in the rppA reporter studies, deleted regiolarge multifunctional polyketide synthase (PKS) / non-
ribosomal peptide synthetase (NRPS) systems, comprising
multi-fatty acid synthase-like domains arranged in sets of
modules [6]. FK506 gene cluster from Streptomyces sp.
MA6548 (ATCC53770) encoding the biosynthesis of this
important drug was partially sequenced by Merck
Research Laboratories [7-10]. In recent years, two entire
gene clusters from Streptomyces sp. KCTC 11604BP and
Streptomyces kanamyceticus KCTC 9225 [11], and a par-
tial sequence of the FK506 gene cluster from Streptomyces
tsukubaensis NRRL 18488 [12] have been published, thus
allowing for the first time a comparative analysis of gene
clusters involved in the formation of FK506 by different
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bolite biosynthesis could play a significant role in improve-
ment of industrial strains, as has been exemplified in the
past [13]. Regulation of secondary metabolism in actino-
mycetes is often diverse and complex and the production
of active natural products is linked to many environmental
and physiological signals [14]. In addition to numerous
pleiotropic regulatory genes present in genomes of sec-
ondary metabolite-producing actinomycete strains, most
of gene clusters encoding secondary metabolite bio-
synthesis contain pathway-specific regulatory genes, such
as the SARP (Streptomyces antibiotic regulatory protein)
family regulators [15] or the LAL (large ATP-binding
regulators of the LuxR family) family regulators [16,17].
Like the SARP family, the LAL family gene-homologues
with end-to-end similarity appear to be confined to the
actinomycetes [18].
The production of many important polyketides or other
secondary metabolites often remains relatively low and
improving production titers of these low-yield compounds
has been of great interest to the industry. This is particu-
larly the case when considering FK506 and structurally
related products, which are produced at rather low yields,
compared to well established antibiotics of microbial ori-
gin such as penicillin, tetracyclines or polyether antibiotics
[19]. Limited regulation aspects of rapamycin and FK520
biosynthesis have been studied in recent years [20-23].
Two regulatory genes, rapH and rapG, were identified in
the rapamycin biosynthetic cluster and their role in regu-
lation of rapamycin biosynthesis was confirmed [20].
Rapamycin RapH and its homologue in the FK520 biosyn-
thetic cluster FkbN both belong to the LAL family of tran-
scriptional regulators [16,24] since they both contain a
LuxR-type helix-turn-helix (HTH) DNA binding motif at
the C terminus [25] and an ATP-binding site at the N
terminus [26]. In addition to fkbN, the gene cluster for
FK520 biosynthesis from Streptomyces hygroscopicus var.
ascomyceticus also contains a second regulatory gene,
termed fkbR1, belonging to the LysR-type transcriptional
regulators (LTTR) [21].
Until recently, regulatory genes have not been systema-
tically investigated in FK506-producing strains. In the
course of our recent work on FK506 biosynthesis [12,27]
we have obtained a complete sequence of the FK506
biosynthetic cluster from Streptomyces tsukubaensis NRRL
18488. The obtained sequence allowed us to compare the
putative regulatory elements present in our sequence with
the other three FK506 gene clusters [11]. In addition, we
have evaluated the role of three putative regulatory genes in
the FK506 biosynthetic cluster using gene inactivation and
over-expression approaches, as well as studied the tran-
scription of FK506 biosynthetic genes in the mutant
strains. In this work, we have demonstrated, that the
biosynthesis of the FK506 in Streptomyces tsukubaensisNRRL 18488 is regulated by two positively-acting regu-
latory proteins, and remarkably, compared to the ap-
parently closely-related strain, Streptomyces sp. KCTC
11604BP [28], it differs substantially.Methods
Bacterial strains and culture conditions
We based our studies on Streptomyces tsukubaensis
NRRL 18488 strain [12], a wild type progenitor of the
industrially used FK506 high-producing strains. For
spore stock preparation S. tsukubaensis strains were
cultivated as a confluent lawn on the ISP4 agar sporula-
tion medium [29] for 8–14 days at 28°C. For liquid cul-
tures spores of S. tsukubaensis strains were inoculated
in seed medium VG3 (0.25% (w/v) soy meal, 1% dex-
trin, 0.1% glucose, 0.5% yeast extract, 0.7% casein
hydrolyzate, 0.02% K2HPO4, 0.05% NaCl, 0.0005%
MnCl2 × 4H2O, 0.0025% FeSO4 × 7H2O, 0.0001%
ZnSO4 × 7H2O, 0.0005% MgSO4 × 7H2O, 0.002%
CaCl2, pH 7.0) and incubated at 28°C and 250 rpm for
24–48h. 10% (v/v) of the above seed culture was used
for the inoculation of production medium PG3
(9% dextrin, 0.5% glucose, 1% soy meal, 1% soy pep-
tone, 1% glycerol, 0.25%.
L-lysine, 0.1% K2HPO4, 0.15% CaCO3, 0.1% polye-
thylene glycol 1000, pH 6.5) [12,29]. Cultivation was
carried out at 28°C, 250 rpm for 6–7 days. Kanamycin
(25 μg/mL) and apramycin (50 μg/mL) were added to the
solid and liquid media after sterilization as required.Recombinant DNA methods and bioinformatic analysis
Genomic DNA for sequencing and PCR amplification
was prepared using standard procedures [30]. Plasmid
vectors were propagated in E. coli DH10β grown in 2TY
medium [31]. S. tsukubaensis transformation was carried
out using E. coli-Streptomyces conjugation procedure
with E. coli ET12567 containing the conjugation-
facilitating plasmid pUZ8002 [32]. General Streptomyces
strain manipulation was carried out using standard
methods [30]. DNA manipulation was carried out using
standard techniques [31]. Sequencing of the FK506 bio-
synthetic cluster of S. tsukubaensis NRRL 18488 strain
was completed using 454 sequencing technology [33] at
Macrogen, Inc., South Korea. DNA sequences covering
the complete FK506 biosynthetic cluster and the right
fringe of the FK506 gene cluster were deposited to the
GenBank database with accession numbers [JX081655]
and [JQ945188], respectively. Web-based versions of
sequence database tools (BLAST programs at the NCBI
server) and GC-content visualization (FramePlot pro-
gram) were used for bioinformatic analyses [34-36].
ClustalW algorithm was used for DNA and protein
sequence alignment [37].
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tsukubaensis strains
Primers for PCR amplification and cloning of the target
putative allN, fkbN and fkbR genes (primers 1-6, see
Additional file 1) were designed based on the newly
acquired sequence of the S. tsukubaensis genome [12].
NdeI and XbaI restriction sites were incorporated via
primers at the putative start codon and after the stop
codon, respectively. PCR amplification was done using the
PhusionW High-Fidelity DNA Polymerase (Fermentas). All
PCR-generated fragments were purified using the
WizardW SV Gel and PCR Clean-Up System (Promega)
after electrophoresis. The PCR fragments were initially
cloned into pUC19 and their DNA sequence confirmed
by sequencing. Further, the selected DNA fragments were
excised from pUC19 using NdeI and XbaI restriction
enzymes, gel purified and subcloned into the phiC31-
based integrative expression vector pSET152, containing
the constitutive ermE* promoter and a Streptomyces ribo-
some binding site [38], via NdeI and XbaI restriction sites,
thus generating plasmids pDG1 (allN), pDG2 (allN+mgl),
pDG3 (fkbR) and pDG4 (fkbN) (Table 1).
By using a constitutive promoter ermE*, we reduced
the potentially self-regulatory property of AsnC and
LysR-type regulators, which are reported in the literature
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WT allN+mgl pDG2 PermE*
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pMB6 PfkbGstrength of the ermE* promoter from Saccharopolyspora
erythraea in the S. tsukubaensis NRRL 18488 strain was
demonstrated previously in our work based on a reporter
system, using the chalcone synthase rppA gene [41].
Targeted gene disruption via homologous recombination
We designed primers for amplification of the regions
flanking the allN, fkbR and fkbN genes (primers 8-19,
see Additional file 1). For the in-frame deletion of the
allN gene, the upstream flanking region was amplified
using primers containing EcoRI and XbaI sites and the
downstream flanking region using primers containing
XbaI and HindIII sites, thus generating a 292 bp in-
frame gap in the 465 bp allN gene. For the disruption of
fkbR the upstream flanking region was amplified using
primers containing XbaI and NdeI sites and the down-
stream flanking region using primers containing NdeI
and HindIII sites, thus generating a 556 bp in-frame gap
in the 942 bp fkbR gene (Figure 2B; Additional file 2).
For the disruption of fkbN the upstream flanking region
was amplified using primers containing HindIII and
NdeI sites and the downstream flanking region using
primers containing NdeI and XbaI sites, thus generating
a 1869 bp deletion in the 2769 bp fkbN gene (Figure 2A;
Additional file 2). The PCR products were gel purified
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rppA 15 Promoter activity
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rppA 15 Promoter activity
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Figure 2 Schematic representation of disruption plasmids and inactivated fkbN (A) and fkbR (B) genes after secondary recombination.
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ments were then excised from pUC19 using the corre-
sponding restriction sites, that were introduced via
primers, and gel purified. Both flanking regions were then
subcloned simultaneously into the temperature-sensitive
vector pKC1139 [42], containing a temperature-sensitive
origin of replication in streptomycetes, which that was pre-
viously digested with corresponding restriction enzymes
(EcoRI-HindIII for allN, XbaI-HindIII for fkbR and
HindIII-XbaI for fkbN flanking regions), thus generating
plasmids pDG5, pDG6 and pDG7 (progenitor of pDG8),
respectively (Table 1). The primers for amplification of the
regions flanking the target genes were specifically designed
in order to create in-frame deletions after double cross-
over recombination, thus avoiding the disruption of down-
stream genes due to polarity effect. In the case of the fkbN
gene there was no need to ensure an in-frame deletion, be-
cause its coding sequence is located at the terminal position
of the bicistronic mRNA and therefore the occurrence of a
polar effect on downstream genes was not an issue
(Figure 1B). Therefore, gene disruption procedure of the
fkbN gene was aided by the introduction of a kanamycin re-
sistance cassette in order to simplify the otherwiselaborious identification of secondary recombinants. In
order to introduce the kanamycin resistance cassette, the
pDG7 plasmid containing the fkbN flanking regions was
digested using NdeI, blunt-ended and dephosphorylated. A
1323 bp blunt-end fragment containing the kanamycin re-
sistance cassette was excised from the SuperCos 1 cosmid
vector (Stratagene) and then ligated into the vector, result-
ing in pDG8 (Table 1). The disruption plasmids pDG5,
pDG6 and pDG8 were then introduced into electrocompe-
tent E. coli strain ET12567 containing the conjugative plas-
mid pUZ8002 [32,43]. The conjugation procedure was
carried out as described previously [42]. Exconjugants were
grown at 28°C on ISP4 sporulation medium with addition
of apramycin (pKC1139). Exconjugants were then inocu-
lated into VG3 medium and cultivated at 28°C and 220
rpm to obtain a good seed culture [30]. After 24 hours, the
cultures were reinoculated into a new tube with fresh VG3
medium and cultivated at 37°C. Above 34°C the pKC1139-
based vector is unable to replicate and is forced to integrate
into the S. tsukubaensis genome via homologous regions,
thus yielding primary recombinants. The cultures were
then further subcultivated at 37°C several times in VG3
medium and then plated onto the ISP4 sporulation
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were plated onto the sporulation medium without apramy-
cin (with kanamycin in the case of fkbN disruption). After
5–8 days of cultivation at 28°C single colonies were replica-
plated onto plates without antibiotic and plates with apra-
mycin (both with kanamycin in the case of fkbN). Primary
recombinants were still resistant to apramycin, while sec-
ondary recombinants lost apramycin resistance. The apra-
mycin sensitive colonies were further screened using PCR
to confirm the deletion. In the case of fkbN, the final
screening step was simplified by the addition of kanamycin
to the medium which precluded the growth of revertants to
wild-type after secondary recombination, which greatly
reduced the time and effort required to screen for correct
secondary recombinants using PCR. After the stable sec-
ondary recombinants were identified and verified by PCR a
double mutant was additionally generated in which both
the fkbR and fkbN genes inactivated. Taking the ΔfkbR
strain as the starting point we disrupted the fkbN gene
using the same procedure as described above. Finally, all
mutant strains were tested for FK506 production.
Evaluation of the promoter activity of the selected genes
from the S. tsukubaensis NRRL 18488 FK506 gene cluster
using rppA reporter system
To study the promoter activity of selected genes from
the FK506 gene cluster, which might be under control of
FkbN and FkbR transcriptional regulators, we con-
structed reporter plasmids based on the chalcone syn-
thase gene rppA from Saccharopolyspora erythraea,
which was employed successfully in previous studies
[20,41]. A series of plasmids were constructed contain-
ing the rppA gene as a reporter under the control of
different promoters. Six putative promoter regions
were selected; PallA, PfkbR, PfkbN, PfkbB, PfkbG, and PermE*
(positive control), yielding plasmid constructs pMB1-6,
representing different regions of the FK506 gene cluster
(Table 1, Figure 1B). All promoter regions, except PermE*,
were PCR-amplified from S. tsukubaensis (NRRL 18488)
genomic DNA. For PCR reactions primers were
designed (primers 20-31, see Additional file 1) in a way
to amplify approximately 500 bp of DNA upstream of
the selected CDSs. PCR-amplified DNA fragments were
gel-purified and ligated into the pUC19 vector. Their
nucleotide sequence was confirmed by sequencing. The
PCR-derived promoter fragments, containing EcoRI and
NdeI sites were then fused at the NdeI site with the
PCR-derived rppA gene, containing NdeI and XbaI and
sub-cloned into pSET152 via EcoRI and XbaI sites. The
“promoterless” rppA gene was also cloned into pSET152
and used in this experiment as a negative control. The
plasmid constructs were then conjugated into S. tsuku-
baensis using E. coli-Streptomyces conjugation procedure
as described earlier. Selected apramycin-resistantconjugants of S. tsukubaensis were cultivated in the PG3
production medium as described above until approxi-
mately 140 hours post inoculation. The culture broth
was then centrifuged and the supernatant diluted 10
times and quantification of water-soluble dark-red flavio-
lin products of the chalcone synthase was carried out
spectrophotometrically using the same conditions as
described previously [41]. 270 nm was identified as the
most appropriate wavelength for sample analysis and the
expression of the rppA gene is presented as absorbance
units (AU), taking into account the dilution factor. Thus,
1 AU represents the amount of flaviolin, which produces
the difference in absorbance of 1 between the sample
with an active promoter and the sample containing pro-
moterless plasmid (blank) of the same strain at 270 nm
(ΔA270).Gene expression analysis by reverse transcriptase PCR
(RT-PCR)
In order to investigate further expression of regulatory
genes and their influence on the expression of FK506-
biosynthetic genes using a semi-quantitative RT-PCR
approach, we have attempted to isolate good quality
mRNA from cultures cultivated in the industrial produc-
tion media (described above), but we were not successful.
We therefore designed a simplified production media,
which still contained the key ingredients from the indus-
trial media. Simplified production medium SPM2 (6% sol-
uble starch, 1% glucose, 0.2624% L-leucine, 0.25%
L-lysine, 0.56% sodium lactate (60%), 1% MOPS, 0.05%
NaCl, 0.05% MgSO4×7H2O, 0.0025% FeSO4×7H2O,
0.0005% MnCl2×4H2O, 0.001% ZnSO4×7H2O, 0.0003%
CoCl2×6H2O, 0.0003% CuSO4×5H2O, pH 6.8) still gave a
reasonable and relatively reproducible yield of around 20
mg/L of FK506 at the end of fermentation, as well as
enabled good quality mRNA isolation. For the purpose of
mRNA isolation, spores of S. tsukubaensis strains (1% v/v)
were inoculated in the defined seed medium SVM2 (2%
(w/v) soluble starch, 2% glucose, 2% yeast extract, 0.05%
NaCl, 0.05% MgSO4×7H2O, 0.1% KNO3, 0.0025% FeS-
O4×7H2O, 0.0005% MnSO4×H2O, 0.001% ZnSO4×7H2O,
0.002% CaCl2×2H2O, pH 7.0) and incubated at 28°C and
220 rpm for 38 h. 10% (v/v) of the above seed culture was
used for the inoculation of a 500-mL Erlenmeyer flask
containing 100 mL of the production medium SPM2.
Cultivation was carried out at 28°C, 220 rpm for 6–7 days.
For RNA extraction, 200 to 500 μL of culture (inverse
proportion to the culture age) were added to 2 volumes
of RNA Protect Bacteria Reagent (Qiagen), mixed by
vortex (30 s) and kept 5 min at room temperature. The
cell pellet was harvested by centrifugation (5 min, 10000 g),
the supernatant was removed and samples were saved
at -80°C.
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described by Tunca et al. [43]. The cell pellets were
resuspended in 900 μL lysis solution [400 μL acid phe-
nol, 100 μL CIA (chlorophorm:isoamyl alcohol; 24 :1),
400 μL RLT buffer (RNeasy mini kit; Qiagen)] and dis-
rupted with a Fastprep instrument (BIO 101) by using
the lysing matrix B (MP Biomedicals). Two pulses of 30
seconds and 6.5 of intensity were applied with cooling
down for one minute on ice between pulses. Aqueous
phase (containing RNA) was recovered after 10 minutes
and 10000 g of centrifugation. Equal volume of CIA was
added and the aqueous phase was again recovered after
centrifugation (5 min, 10000 g). Subsequently, total RNA
was isolated using an RNeasy mini kit (Qiagen) following
the supplier’s indications. A second DNA removing step
was carried out in solution using Ambion's TURBO
DNA-free DNase. DNA contamination was tested for
every set of primers (see Additional file 3) to confirm
the absence of contaminating DNA in the RNA prepara-
tions. RNA concentration was calculated spectrophoto-
metrically by determining the absorbance at 260 nm.
RT-PCR analysis was performed by using the Super-
scriptTM One-Step RT-PCR with PlatinumW Taq system
(Invitrogen) with 50 ng of RNA as template and 35
cycles of amplification. Primers (see Additional file 3)
were designed to generate PCR amplicons in the range
of 200-500 bp and the annealing temperatures 55°C to
70 °C. Primer specificity was tested in silico by using the
software available on the web site http://insilico.ehu.es
[44]. Positive controls were done using as template total
DNA of S. tsukubaensis.
FK506 detection and quantification
Generally, at least nine independent exconjugants of each
engineered strain were selected for further experiments.
Data were obtained from at least two independent fer-
mentation experiments. Extraction of FK506 and HPLC
analysis were performed as described previously [12].
Briefly, after 6-7 days of cultivation the broth was mixed
with the equal volume of methanol (1:1). Samples were
filtrated and loaded onto Nucleosil EC100-3 C18,
reversed-phase HPLC column. The mobile phase used for
isocratic elution was composed of water, acetonitrile,
MTBE and phosphoric acid (58.29:34.4:7.29:0.02, v/v/v/v).
Chromatographic peaks corresponding to FK506 were
identified and quantified using an FK506 external stand-
ard (obtained from Lek/Sandoz) and ChromQuest soft-
ware was used for the data analysis. The calibration curve
was generated using external standard prepared in the
mobile phase and linear response was observed in con-
centration range from 1 to 1000 mg/L. Samples were ana-
lyzed immediately after each cultivation and for each
experiment external standard was used for quantification.
To obtain statistically significant results, each colony wasrepresented by two parallel samples. Yields of FK506 were
calculated with SAS/STAT software using means and the
univariate procedure to test the normality of distribution.
Using the GLM model, data were calculated as least
mean square and are presented as an average change
observed from all experiments when comparing least
mean square values to the wild-type control least mean
square value of each experiment.
Results
Bioinformatic analysis of the putative regulatory genes
Bioinformatic studies of the FK506 gene cluster from
Streptomyces tsukubaensis NRRL 18488 revealed three
potential regulatory genes; namely fkbR, fkbN and allN
(Figure 1B). Two of the three putative regulatory genes,
are located at the right side from the PKS core region,
together with three coding sequences (CDSs) involved in
biosynthetic reactions (Figure 1B), similarly to gene
organization in the related FK506 biosynthetic cluster in
Streptomyces sp. KCTC 11604BP [11]. The fkbN gene
encodes a putative transcriptional regulator belonging to
the LAL family [16,24] and fkbR encodes a putative tran-
scriptional regulator belonging to the LTTR family and
seems to represent the right limit of the FK506 gene
cluster (Figure 1B). The product of the fkbN gene was
originally typized by the regulator of the maltose regulon
in Escherichia coli MalT [45]. These regulators are rela-
tively large in size (872-1159 aa) compared to the better-
studied SARPs (277-665 aa) [15] and they have been
identified in several macrolide antibiotic pathways,
including FkbN from Streptomyces hygroscopicus var.
ascomyceticus in FK520 biosynthesis [21], PikD from
Streptomyces venezuelae for pikromycin [46], RapH from
Streptomyces hygroscopicus for rapamycin [20,24,47],
NysRI/RIII from Streptomyces noursei for nystatin [48]
and GdmRI and GdmRII from Streptomyces hygroscopi-
cus 17997 for geldanamycin biosynthesis [49]. DNA
sequence of the fkbN gene from S. tsukubaensis strain
shares 69.9% amino acid identity (79.3% similarity) with
FkbN from the FK520 cluster of S. hygroscopicus var.
ascomyceticus and 57.4% amino acid identity (67.2%
similarity) with RapH from the rapamycin cluster of S.
hygroscopicus. The second regulatory gene, fkbR, displays
all the usual characteristics of the LTTR family of tran-
scriptional regulators; similar size (314 aa), a N-terminal
HTH motif (residues 1-62) and the well conserved
substrate-binding domains involved in co-inducer recog-
nition and/or response [40,50,51]. Homologues of fkbR,
the LTTRs, compose a family of autoregulatory tran-
scriptional regulators that regulate very diverse genes
and functions and are among the most common positive
regulators in prokaryotes [40,51]. They generally do not
exceed 325 aa residues in size, which was of great
importance in assigning the correct start codon of fkbR
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fringe of the cluster suggests that an intergenic region of
430 bp seems to be present between the fkbR and
thioesterase-encoding fkbQ genes, which are transcribed
in opposite directions (Figure 1B).
In contrast to fkbN and fkbR, the third regulatory gene
allN is located on the left fringe of the FK506 gene cluster
where we have originally identified a number of CDSs
involved in the provision of allylmalonyl-CoA [11,12]. The
allN gene is a member of the AsnC family regulatory
proteins, named after the asparagine synthetase activator
from E. coli, which is known to be involved in the regula-
tion of amino acid metabolism.
Yield of FK506 is highly dependent on the expression of
fkbN and fkbR regulatory genes
In the next step our aim was to functionally characterize
the three identified regulatory gene homologues in the
FK506 biosynthetic cluster by gene-inactivation and
overexpression experiments and to evaluate the possibil-
ities for increasing FK506 yield by obtaining genetically
engineered strains of S. tsukubaensis. It was not straight-
forward to identify the correct start codon for the CDS
of the fkbN regulatory gene, since there are two possible
start-codon sites located only 9 bp apart. We therefore
amplified both versions of the gene, the longer fkbN and





























Figure 3 Yield of FK506 by different strains of S. tsukubaensis. Bars en
the median values, and perpendicular lines indicating extreme values (min
between different samples compared to control wild type samples (WT). Th
Methods. Introduction of additional “in trans” copies of target putative regu
WT:R-fkbR over-expressed, WT:N-1 (shorter version of fkbN over-expressed),
tsukubaensis genes (ΔR-fkbR inactivated, ΔN-fkbN inactivated) and complem
ΔRN:N-fkbR, fkbN double mutant complemented only with fkbN, ΔN:N-fkbNexperiments using both PCR-amplified fkbN variants.
The second copy of each version of the fkbN gene was
introduced into the S. tsukubaensis wild type strain
under the control of the strong ermE* promoter and
Streptomyces ribosomal binding site (RBS) [38], a com-
bination which was previously observed to enable high-
level protein expression in this strain [41]. Overexpres-
sion of either version of fkbN resulted in improved
FK506 production. In fact, the longer version of the fkbN
gene proved to be more effective in increasing FK506
titers. An approximate raise in FK506 yield of 55% was
observed in a growth medium that closely resembles
industrial conditions when fkbN was introduced into the
wild-type strain, while the shorter fkbN-1 increased
FK506 production by 38% (Figure 3). This demonstrates
that the region surrounding the ATP-binding site at the
N terminus of FkbN is important for complete function-
ality of the protein.
In contrast, inactivation of the fkbN gene caused
complete disruption of FK506 biosynthesis (Figure 3),
clearly demonstrating the key role of FkbN in the regula-
tion of FK506 biosynthesis. When preparing the fkbN
inactivated mutant (ΔfkbN) strain, a kanamycin resis-
tance cassette was inserted into the fkbN CDS
(Figure 2A). There was no need to ensure an in-frame
deletion, considering that its coding sequence is located at
the terminal position of the bicistronic mRNA andT:R* R* R:R RN* RN:N* RN:R*
train
compass 95% of the sample population. Horizontal line representing
, max). Asterisks where representing statistically significant differences
e data were analyzed using SAS/STAT program as described in
latory genes using phiC31-based integrative vector [WT-wild type,
WT:N-fkbN over-expressed, inactivation of target putative regulatory S.
entation experiments (ΔR:R-fkbR mutant complemented with fkbR,
mutant complemented with fkbN)].
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(Figure 1B). Finally, we have also carried out the comple-
mentation experiment with fkbN under the control of the
constitutive ermE* promoter together with a Streptomyces
RBS [38] in the ΔfkbN strains. After complementation
FK506 production was only partially restored and reached
47% of the wild-type production. The ΔfkbN strains were
complemented using the longer variant of the gene, which
proved to be more effective in raising FK506 production
in over-expression experiments. We have also comple-
mented ΔfkbRΔfkbN-double inactivated mutant strains.
Interestingly, double “knock-out” mutants complemented
with fkbN, reached comparable FK506 production levels
(43%) to the ΔfkbN complemented strains (Figure 3).
Therefore, although ermE* promoter (and heterologous
RBS) is expressed strongly in S. tsukubaensis, as demon-
strated previously by our group [41], it does not seem to
be a suitable promoter to match “native” activity, which
might require a specific mechanism of gene regulation,
possibly also binding of a potential co-inducer. It is pos-
sible that the complementation experiment in the case of
fkbN gene may have been influenced by the fact that
although the transcription of fkbN gene was inactivated by
deleting a big part of the CDS and inserting a kanamycin
resistance cassette, the remaining parts of the gene,
including the C-terminal DNA binding domain could still
be expressed (see Additional file 2). Such truncated pro-
teins could potentially interfere with the function of intact
FkbN protein, produced in the complementation experi-
ment. All this shows, that FkbN is indispensable for
FK506 production, which is in agreement with recently
published results [28]. Clearly, fkbN also shows important
potential for application in genetic/metabolic engineering
of industrial FK506 producing strains.
In the next step, an additional copy of the fkbR gene was
introduced into S. tsukubaensis under the control of the
ermE* and Streptomyces RBS [38]. Like in the case of fkbN,
FK506-production was increased demonstrating that fkbR
also has a positive regulatory role in S. tsukubaensis NRRL
18488. However, yield increase was moderate with FK506
production approximately 30% higher than in the control
strain (Figure 3). The fkbR gene-disrupted mutants
(Figure 2B; Additional file 2) displayed a significant reduc-
tion in FK506 production and on average they retained only
approximately 20% of the wild-type production level, clearly
demonstrating a positive role of this regulatory protein.
Unlike FkbN, the FkbR regulatory protein is not indispens-
able for FK506-production. Interestingly, the ΔfkbR strains,
complemented with the fkbR gene transcribed under the
ermE* promoter showed recovery of FK506 production to
wild-type levels (Figure 3). As expected, double mutant
strains ΔfkbRΔfkbN were unable to produce FK506.
Neither addition of a second copy of the allN gene
transcribed under the ermE* promoter, nor theinactivation of allN, located on the left fringe of FK506
gene cluster, showed any influence on FK506 production
or any other phenotypic characteristic (e.g. morpho-
logical), as the mutant strains retained wild-type values
of FK506 yield. The result was the same when allM and
allN were overexpressed together.
Gene expression in FK506 gene cluster is not abolished
by inactivation of fkbN or fkbR
In the next step we aimed to identify genes in the FK506
gene cluster, the transcription of which could possibly be
regulated by FkbN and FkbR transcriptional regulators.
We constructed reporter plasmids based on the rppA
gene chalcone synthase from S. erythraea, described
previously [20,41]. For the purpose of this work, we
selected six different approximately 500-bp long putative
promoter regions, located upstream of start codons of
representative CDSs of the FK506 gene cluster. This
allowed us to study the activity of putative promoters of
predicted operons which encode different biosynthetic
functions:
1) the promoter PallA from allA gene located in the “all”
subcluster (Figure 1B), which encodes a small
diketide synthase system, part of a larger operon of
four CDSs involved in the biosynthesis of
allylmalonyl-CoA extender unit [12],
2) PfkbR and PfkbN promoters of CDSs encoding
regulatory proteins FkbR and FkbN, respectively,
which are located at the right fringe of the FK506
gene cluster,
3) PfkbB, a promoter of the largest CDS in the FK506
gene cluster encoding a PKS core region and
4) promoter PfkbG of fkbG, a gene encoding a
O-methyltransferase, located in the group of genes
involved in the methoxymalonyl-ACP extender unit
biosynthesis [21].
Promoter PermE*, which was used as a control gave a
strong consistent signal, confirmed by the constant
expression of rppA in all tested S. tsukubaensis strains
with engineered regulatory genes (Figure 4).
Wild type and fkbN- and fkbR-inactivated strains con-
taining these plasmids were cultivated for approximately
140 hours whereupon the promoter activity of the
cloned regions was assessed. Based on the rppA reporter,
a significant change of expression was observed with
PfkbB, the promoter of the gene encoding the largest cod-
ing sequence in the FK506 gene cluster, the first core
PKS gene fkbB. In the wild-type strain, relatively high
rppA reporter expression was observed under the con-
trol of PfkbB promoter comparable to the control PermE*
promoter, which is generally considered to be a strong
Streptomyces promoter [52]. In the engineered mutant
Goranovič et al. BMC Microbiology 2012, 12:238 Page 10 of 15
http://www.biomedcentral.com/1471-2180/12/238strains of S. tsukubaensis however, the identical con-
struct containing the rppA gene under PfkbB, displayed
significantly reduced production of colored flaviolin,
58% and 50% of the wild-type level for ΔfkbR and ΔfkbN
inactivated strains, respectively (Figure 4). Interestingly,
a complete loss of PfkbB activity was not observed, even
though FK506 production was completely abolished in
ΔfkbN strains. In addition, we also observed a drop in
activity of PfkbG in both fkbR and fkbN inactivated
strains. Although this experiment indicates, that expres-
sion of fkbG is at least partially regulated by FkbR and
FkbN, relatively low signal and significant variations in
absorbance among different independent strains were
observed (Figure 4). Surprisingly, in all tested strains, in
which the promoters PallA, PfkbR and PfkbN were tested,
no differences in the OD270nm values were observed,
indicating very low levels of expression of the rppA
reporter gene. This suggests a relatively low-level activity
of these three promoters and, consequently, low level of
expression of the genes encoding key steps in the
substrate supply of the unusual extender unit, allylmalo-
nyl-CoA, potentially influencing the ratio of undesired
congener FK520.
In order to complement the interesting observations
obtained by the chalcone synthase rppA gene-based
reporter system, we also carried out semi-quantitative
RT-PCR analysis of potential target genes of FkbN and
FkbR (Figure 5B). Total RNA was isolated from the wild-
type strain, fkbR and fkbN mutants after 36, 72 and 103
hours of growth in a modified liquid medium SPM2
(as described in Methods). We selected these intervals on
the basis of FK506 production, which we followed in theFigure 4 Promoter activity represented as expression of the reporter
(light gray – WT, dark gray – ΔfkbR, white – ΔfkbN). The ΔA values rep
with an active promoter and the sample derived from the same mutant stsame medium that was used for RNA preparation. FK506
production was first detected after approximately 50-60
hours and the production was highest around 70-80 hours
of cultivation. After 103 hours of cultivation the culture
was in the late stationary phase but was still producing
FK506 at a moderate level (Figure 5A).
Interestingly, transcription of fkbR was observed
already at early stage of cultivation (36 hours) and con-
tinued throughout the entire fermentation process. On
the contrary, expression of fkbN was not observed in
early stages of the fermentation process (before 36
hours) and was only detected around the onset of FK506
production (Figure 5B).
Surprisingly, inactivation of the fkbN gene, although
completely abolishing FK506 biosynthesis, did not prevent
the transcription of genes tested in the scope of this study.
In agreement with results observed using the rppA
reporter gene, we observed a decrease in transcription of
fkbG (Figure 5B), the first of the five genes involved in the
methoxymalonyl-ACP extender unit biosynthesis. How-
ever, FkbN protein is clearly not essential for transcription
of fkbG as PCR bands can be clearly observed in the fkbN-
inactivated strain as well as in the WT strain at early
fermentation times when transcription of fkbN is still
below detection limit of RT-PCR analysis (Figure 5B).
In contrast to the observations using the rppA reporter
gene, where transcription of fkbB encoding the first part
of FK506 PKS reduced significantly in fkbN-inactivated
strain, RT-PCR approach did not show significant reduc-
tion of transcription of the fkbB gene.
Interestingly, in most RT-PCR experiments we were
not able to detect any transcripts of the allA gene or ingene rppA in S. tsukubaensis wild type and mutant strains
resent the difference in absorbance at 270 nm, between the sample








WT R N  
36h 72h 103h





























Figure 5 (A) Time course for FK506 production in the SPM2 medium. (B) Gene expression analysis by RT-PCR. Results of transcript analysis
from three strains are presented WT-wild type, ΔR-fkbR inactivated, ΔN-fkbN inactivated. Total mycelial RNA was extracted after 36, 72 and 103
hours of fermentation.
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extremely weak, agreeing with the absence of any acti-
vity of chalcone synthase reporter rppA under the con-
trol of PallA. To re-confirm this result, we have designed
more than one set of primers. The set of primers, which
were used for RT-PCR experiments, resulted in success-
ful amplification of the target PCR-product when DNA
was used as template (data not shown). In conclusion,
RT-PCR as well as rppA reporter gene approach showed
that transcription of the tested FK506 biosynthetic genes
is clearly not abolished upon inactivation of fkbN or
fkbR. While both methods are essentially in agreement
about this most important point, some discrepancies
were observed regarding the changes in the level of
expression for some of the tested genes, most remar-
kably the fkbB PKS gene. These discrepancies are further
discussed below.
Discussion
Biosynthesis of complex polyketides, such as biogeneti-
cally related immunosuppressants FK506 and rapamycin
is likely tightly regulated, considering the complexity ofthe multienzyme machinery, which catalyzes the synthe-
sis of such complex molecules. In this work, we have
identified and characterized the functional role of two
regulatory elements present in the FK506 biosynthetic
cluster of S. tsukubaensis NRRL 18488 (Figure 1B). Our
work, together with recent results of other groups demon-
strates that regulatory mechanisms differ among different
FK506 producing strains even though biosynthetic clusters
appear to be very similar. Interestingly, two types of
FK506 biosynthetic clusters seem to be present in different
FK506 producing strains. The first group comprises
FK506 gene clusters from S. tsukubaensis NRRL 18488
and Streptomyces sp. KCTC 11604BP with very similar
nucleotide sequence and CDS-organization. These two
gene clusters contain several additional CDSs, located in
the “all” group of genes involved in biosynthesis of
allylmalonyl-CoA extender unit, when comparing them to
the second group of gene clusters from Streptomyces
tacrolimicus (formerly Streptomyces sp. ATCC 55098
[53,54]) and S. kanamyceticus KCTC 9225 [11,12]. Gene
clusters of all published FK506-producing strains contain
an fkbN regulatory gene homologue, but only the larger
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and Streptomyces sp. KCTC 11604BP contain another
regulatory gene fkbR and an additional putative regulator
allN [11].
Significantly lower yields of FK506 were generally
observed in the S. tacrolimicus strain, containing the
shorter version of the cluster (our unpublished results),
therefore, the presence of additional biosynthetic and
regulatory genes in the longer variant of the cluster might
be related to better biosynthetic efficiency. Interestingly, it
was reported that heterologous expression of fkbR1, a
distant homologue of fkbR (49% nucleotide sequence iden-
tity, 24% amino acid sequence identity) from the FK520-
producing strain S. hygroscopicus var. ascomiceticus in S.
tacrolimicus resulted in a threefold increase of FK506
production [22,23]. Thus, it is reasonable to propose that
at least one of the reasons for lower production by S.
tacrolimicus strain could be the lack of fkbR regulatory
element, in addition to the frameshift detected in the fkbG
gene (hydroxymalonyl-ACP methyltransferase) [11]. In
agreement with the findings of Won et al. [22,23] who
observed positive effect of the heterologously expressed
fkbR1 gene in S. tacrolimicus, we have demonstrated that
the native fkbR gene has an important role as a positive
regulator of FK506 production in S. tsukubaensis. Overex-
pression of fkbR in the wild type S. tsukubaensis resulted
in a relatively moderate increase in FK506 production,
whereas its inactivation had a remarkable impact and
decreased the production of FK506 to only a fifth of the
wild-type level, clearly demonstrating its role as a positive
regulatory element (Figure 3). In contrast to our findings,
Mo et al. [28] have just recently reported that the tcs7
gene (homologue of fkbR) from Streptomyces sp. KCTC
11604BP has a negative regulatory role. This seems to be a
somehow surprising result considering extremely high
degree of similarity of both FK506 biosynthetic clusters on
the level of DNA sequence [11,28]. One possible expla-
nation is that the two strains have different general (pleio-
tropic) regulatory networks and/or backgrounds of
primary metabolic pathways, as has been observed re-
cently in the case of allylmalonyl-CoA extender unit bio-
synthesis. In that case, the role of one of the FK506
biosynthetic genes (allR-tcsC) was found to differ signifi-
cantly in both strains in spite of identical nucleotide
sequence of the gene. In Streptomyces sp. KCTC 11604BP
this homologue of crotonyl-CoA carboxylase/reductase is
involved exclusively in the biosynthesis of the allylmalo-
nyl-CoA, an unusual building block of FK506 while on the
other hand, in S. tsukubaensis allR also takes part in the
biosynthesis of ethylmalonyl-CoA and thereby in the co-
production of the FK520 impurity [11,27]. Comparative
genomic analysis of these two strains should be carried
out in the future in order to clarify the observed diffe-
rences. Notably, in order to evaluate the potential ofregulatory genes for increasing the yield of FK506 we car-
ried out our experiments in media that closely resemble
industrial conditions and therefore obtained considerably
higher FK506 production. This may represent another
explanation for the apparently divergent role of fkbR/tcs7
in S. tsukubaensis NRRL 18488 and Streptomyces sp.
KCTC 11604BP.
It was interesting to observe that when the ΔfkbN
strain was complemented by overexpression of fkbN
under the strong constitutive ermE* promoter, the
FK506 production was not reestablished to its wild type
levels. While the use of a heterologous constitutive
ermE* promoter is one possible cause, another potential
cause for only partial restoration of FK506 production of
the complemented ΔfkbN strain may be that the fkbN
gene was inactivated by replacing a central part of its
CDS with a kanamycin resistance cassette. In this way,
the N-terminal part of the CDS remains intact and may
produce truncated proteins (Figure 2, Additional file 2).
Such truncated fragments might potentially interfere
with the normal function of intact FkbN proteins,
expressed under the control of ermE* in the scope of the
complementation experiment.
To evaluate the influence of fkbN and fkbR regulatory
genes on the expression of FK506-biosynthetic genes, we
carried out a transcriptional analysis of several selected
genes using RT-PCR and, in parallel, the rppA chalcone
synthase reporter system [20,41]. The main advantage of
the rppA reporter is that it allows the use of nutrient-rich
industrial media without any modification. Based on this
reporter system, and in line with the hypothesis, that FkbR
and FkbN are positive regulatory elements, we observed a
decrease of expression of the PKS gene fkbB and possibly
also of the methyl transferase gene fkbG, involved in
biosynthesis of the methoxymalonyl-ACP extender unit in
ΔfkbR and ΔfkbN mutant strains (Figure 4).
Considering that FK506 production was completely
abolished in ΔfkbN strains, it is intriguing why the acti-
vity of PfkbB, was decreased in ΔfkbR and ΔfkbN strains
to only approximately 58% and 50%, respectively, while a
complete loss of the PfkbB activity has not been observed.
Interestingly, a very similar phenomenon was observed
in the rapamycin gene cluster from S. hygroscopicus
strain [20] and picromycin gene cluster from Strepto-
myces venezuelae [46]. These observations suggest that
post-transcriptional regulation of polyketide biosynthesis
may be an important and so far unexplored mechanism,
possibly in part mediated by currently known regulatory
proteins. It should be noted that a rare codon UUA is
present in the fkbN transcript, providing an additional
opportunity for translational regulation [55].
Further on, it is interesting to compare the results of
rppA reporter gene experiments with the data obtained
by RT-PCR experiments. Most importantly, both
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vation of transcription of all FK506 biosynthetic genes
does not occur neither in ΔfkbR nor in the ΔfkbN strain,
in which no FK506 is produced. In addition, both
approaches showed a decrease of fkbG expression in the
ΔfkbN strain (Figures 4 and 5B). This suggests that FkbN
may positively regulate the expression of the genes
involved in the methoxymalonyl-ACP extender unit
biosynthesis at transcription level. On the other hand, it
is intriguing to observe some degree of discrepancy
between the two approaches, for example in the effect of
FkbN and FkbR inactivation on fkbB expression. While
rppA reporter system showed significant reduction of
fkbB transcription (see above) the RT-PCR approach, in
contrast, did not suggest any effect of fkbN inactivation
on the transcription of this core PKS gene. Several rea-
sons may account for the observed differences between
the two approaches in levels of transcription of indivi-
dual genes, for example: A) Flaviolin pigment, which is
eventually produced by the rppA reporter gene, accumu-
lates during the complete period of examination and can
be seen as a “time accumulated” signal up to 140 hours
when the samples were taken for analysis. On the other
hand, RT-PCR provides snap-shot measurements of
transcript levels. Considering that transcription of fkbB
polyketide synthase gene is not completely abolished
according to rppA reporter system, but only reduced to
roughly 50% in the fkbN-inactivated mutants, time-
dependent changes in levels of fkbB transcript may
explain the observed divergence. B) Possibly, regulatory
element(s) located outside of FK506 gene clusters in the
two strains, might have a more prominent influence on
regulation of the biosynthesis of FK506 than previously
expected and may influence differently the PfkbB pro-
moter when located upstream of its native fkbB gene
inside the FK506 cluster in contrast to when it is located
in front of the rppA reporter gene in a different region
of the chromosome. C) Similarly, different context of the
PfkbB promoter in rppA reporter system on one hand
and in its native context on the other, may also give rise
to different results in case truncated FkbN or FkbR pro-
teins are expressed at low level as discussed above. Thus,
our results show that the inactivation of fkbN nor fkbR
had no significant general influence on the expression of
most genes, located in the FK506 gene cluster, with the
possible exception of fkbG, involved in the provision of
methoxymalonyl-ACP. Although the used approaches
enable only semi-quantitative assessment of differences
in promoter activity our results suggest that the produc-
tion of FK506 might in part be controlled by provision
of this unusual extender unit. Obviously, this hypothesis
will have to be explored in more detail in the future.
Interestingly, recently published results by Chen et al.
[56], seem to support this possibility as it wasdemonstrated that the over-expression of the
methoxymalonyl-ACP providing genes under the strong
constitutive promoter ermE* significantly increased the
production of FK506 in S. tsukubaensis. In summary, we
have clearly demonstrated, that inactivation of the fkbN
gene, although completely abolishing FK506 biosynthesis,
did not prevent the transcription of FK506 biosynthetic
genes, contrary to the observations in Streptomyces sp.
KCTC 11604BP strain, where all genes involved in bio-
synthesis of FK506 were silenced [28].Conclusions
Our results demonstrate that a complex regulatory mech-
anism is responsible for activation and complete function-
ality of the FK506 biosynthetic machinery. We show that,
FkbN and FkbR clearly have a positive regulatory role in
FK506 biosynthesis in the S. tsukubaensis strain when
experiments are carried out in industrial-like fermenta-
tion medium. Remarkably, regulation of FK506 biosyn-
thesis in S. tsukubaensis differs substantially from what
has been recently described in Streptomyces sp. KCTC
11604BP [38] although the gene clusters of these two
strains are practically identical on the DNA level. Most
notably, we found fkbR to be a positively acting regulator
in S. tsukubaensis, expressed continuously during the bio-
synthetic process. Moreover, the effect of fkbN inactiva-
tion on transcription levels of FK506 biosynthetic genes
in S. tsukubaensis was not significant enough to account
for complete disruption of FK506 production, suggesting
that additional post-transcriptional regulatory mechan-
isms may be operative in this strain, while transcriptional
regulation was found to be prevalent in Streptomyces
sp. KCTC 11604BP. Significant differences in the regula-
tion observed between these two strains obviously have a
profound influence on the process development efforts at
the industrial scale. Finally, we have demonstrated a
potential for FK506 yield increase in engineered strains of
S. tsukubaensis by simple overexpression of fkbN and
fkbR, which could result in rapid and straightforward
improvement of FK506 yield in the industrial fermenta-
tion process.Additional files
Additional file 1: Table containing primers for PCR amplifications
of the target putative regulatory genes (The file presents
primers and their corresponding sequences, that have been
used for PCR amplification of whole genes or homologous
regions and promoter regions).
Additional file 2: Schematic representation of FkbR and FkbN
protein domains and deleted regions (This file illustrates FkbR and
FkbN proteins and their organization before and after
inactivation).
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